SCHEMBL4923893

SCHEMBL4923893

CC1(C)COP(OCC(C)(C)COP2OCC(C)(C)CO2)OC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925317 0.76
SCHEMBL10976864 0.72
SCHEMBL18455323 0.68
SCHEMBL1193338 0.67
SCHEMBL10341220 0.67 ALDH1A1 (0.34)
Carbon Monoxide SCHEMBL11839192 0.66
SCHEMBL10980701 0.65 PSMB1 (0.43) TSHR
SCHEMBL11145659 0.64 MAOB (0.38) TSHRMAPK1
Bromide SCHEMBL11678467 0.64 ALDH1A1 (0.33)
SCHEMBL13948860 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877956-B2 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions AFTON CHEMICAL CORPORATION (US) 2014-11-04 US disclosed
US-8871696-B2 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions AFTON CHEMICAL CORPORATION (US) 2014-10-28 US disclosed
US-20140066646-A1 1,3,2-Dioxaphosphorinane, 2-Sulfide Derivatives For Use As Anti-Wear Additives In Lubricant Compositions AFTON CHEMICAL CORPORATION (US) 2014-03-06 US disclosed
US-20140066346-A1 1,3,2-Dioxaphosphorinane, 2-Sulfide Derivatives For Use As Anti-Wear Additives In Lubricant Compositions AFTON CHEMICAL CORPORATION (US) 2014-03-06 US disclosed
US-8618030-B2 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions AFTON CHEMICAL CORPORATION (US) 2013-12-31 US disclosed
US-20130281337-A1 1,3,2-Dioxaphosphorinane, 2-Sulfide Derivatives For Use As Anti-Wear Additives In Lubricant Compositions AFTON CHEMICAL CORPORATION 2013-10-24 US disclosed
US-8466096-B2 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions AFTON CHEMICAL CORPORATION (US) 2013-06-18 US disclosed
US-20080269088-A1 non-acidic, sulfur-containing, phosphorus-containing compound of the formula Such a compound may exhibit improved antiwear performance and thermal stability in lubricating compositions. AFTON CHEMICAL CORPORATION 2008-10-30 US disclosed
US-6242658-B1 INVOLVING NICKEL METALLACYCLES (NICKEL TRINEOPENTYLPHOSPHITE)WITH PHOSPHITE LIGANDS E. I. DUPONT DE NEMOURS AND COMPANY 2001-06-05 US disclosed
EP-0889867-A1 PROCESS FOR THE MANUFACTURE OF FLUORINE-SUBSTITUTED HYDROCARBONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-01-13 EP disclosed
WO-1997035820-A1 PROCESS FOR THE MANUFACTURE OF FLUORINE-SUBSTITUTED HYDROCARBONS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269088-A1 non-acidic, sulfur-containing, phosphorus-containing compound of the formula Such a compound may exhibit improved antiwear performance and thermal stability in lubricating compositions. PSPH, PNISR, SRSF1 TSHR 2304/4885MAPK1 672/4885
US-20140066646-A1 1,3,2-Dioxaphosphorinane, 2-Sulfide Derivatives For Use As Anti-Wear Additives In Lubricant Compositions PRDX1, PSPH, PRDX4 TSHR 1768/4885MAPK1 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.